124 related articles for article (PubMed ID: 12643698)
1. A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series.
Corneillie TM; Whetstone PA; Fisher AJ; Meares CF
J Am Chem Soc; 2003 Mar; 125(12):3436-7. PubMed ID: 12643698
[TBL] [Abstract][Full Text] [Related]
2. Formation kinetics and stability studies on the lanthanide complexes of 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid by capillary electrophoresis.
Zhu X; Lever SZ
Electrophoresis; 2002 May; 23(9):1348-56. PubMed ID: 12007137
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system.
Corneillie TM; Fisher AJ; Meares CF
J Am Chem Soc; 2003 Dec; 125(49):15039-48. PubMed ID: 14653738
[TBL] [Abstract][Full Text] [Related]
4. Element-coded affinity tags for peptides and proteins.
Whetstone PA; Butlin NG; Corneillie TM; Meares CF
Bioconjug Chem; 2004; 15(1):3-6. PubMed ID: 14733576
[TBL] [Abstract][Full Text] [Related]
5. An NMR and DFT investigation on the conformational properties of lanthanide(III) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate analogues containing methylenephosphonate pendant arms.
Purgel M; Baranyai Z; de Blas A; Rodríguez-Blas T; Bányai I; Platas-Iglesias C; Tóth I
Inorg Chem; 2010 May; 49(9):4370-82. PubMed ID: 20369836
[TBL] [Abstract][Full Text] [Related]
6. Conformational characterization of lanthanide(III)-DOTA complexes by ab initio investigation in vacuo and in aqueous solution.
Cosentino U; Villa A; Pitea D; Moro G; Barone V; Maiocchi A
J Am Chem Soc; 2002 May; 124(17):4901-9. PubMed ID: 11971741
[TBL] [Abstract][Full Text] [Related]
7. In vitro imaging and human serum albumin responsive dimeric lanthanide DO3A complex.
Fung YO; Wu W; Yeung CT; Kong HK; Wong KK; Lo WS; Law GL; Wong KL; Lau CK; Lee CS; Wong WT
Inorg Chem; 2011 Jun; 50(12):5517-25. PubMed ID: 21591737
[TBL] [Abstract][Full Text] [Related]
8. Complexing mechanism of the lanthanide cations Eu3+, Gd3+, and Tb3+ with 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (dota)-characterization of three successive complexing phases: study of the thermodynamic and structural properties of the complexes by potentiometry, luminescence spectroscopy, and EXAFS.
Moreau J; Guillon E; Pierrard JC; Rimbault J; Port M; Aplincourt M
Chemistry; 2004 Oct; 10(20):5218-32. PubMed ID: 15372580
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic stability, kinetic inertness and relaxometric properties of monoamide derivatives of lanthanide(III) DOTA complexes.
Tei L; Baranyai Z; Gaino L; Forgács A; Vágner A; Botta M
Dalton Trans; 2015 Mar; 44(12):5467-78. PubMed ID: 25695351
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, potentiometric, kinetic, and NMR Studies of 1,4,7,10-tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its complexes with Ca(II), Cu(II), Zn(II) and lanthanide(III) ions.
Kálmán FK; Baranyai Z; Tóth I; Bányai I; Király R; Brücher E; Aime S; Sun X; Sherry AD; Kovács Z
Inorg Chem; 2008 May; 47(9):3851-62. PubMed ID: 18380456
[TBL] [Abstract][Full Text] [Related]
11. A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution.
Al-Ejeh F; Darby JM; Thierry B; Brown MP
Nucl Med Biol; 2009 May; 36(4):395-402. PubMed ID: 19423007
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the conformational behavior and stability of the SAP and TSAP isomers of lanthanide(III) NB-DOTA-type chelates.
Tircso G; Webber BC; Kucera BE; Young VG; Woods M
Inorg Chem; 2011 Sep; 50(17):7966-79. PubMed ID: 21819053
[TBL] [Abstract][Full Text] [Related]
13. A benzimidazole functionalised DO3A chelator showing pH switchable coordination modes with lanthanide ions.
Fisher CM; Fuller E; Burke BP; Mogilireddy V; Pope SJ; Sparke AE; Déchamps-Olivier I; Cadiou C; Chuburu F; Faulkner S; Archibald SJ
Dalton Trans; 2014 Jul; 43(25):9567-78. PubMed ID: 24828602
[TBL] [Abstract][Full Text] [Related]
14. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
[TBL] [Abstract][Full Text] [Related]
15. DOTA-functionalized polylysine: a high number of DOTA chelates positively influences the biodistribution of enzymatic conjugated anti-tumor antibody chCE7agl.
Grünberg J; Jeger S; Sarko D; Dennler P; Zimmermann K; Mier W; Schibli R
PLoS One; 2013; 8(4):e60350. PubMed ID: 23565233
[TBL] [Abstract][Full Text] [Related]
16. Monopropionate analogues of DOTA4- and DTPA5-: kinetics of formation and dissociation of their lanthanide(III) complexes.
Balogh E; Tripier R; Fousková P; Reviriego F; Handel H; Tóth E
Dalton Trans; 2007 Aug; (32):3572-81. PubMed ID: 17680048
[TBL] [Abstract][Full Text] [Related]
17. Lanthanide(III) complexes of 4,10-bis(phosphonomethyl)-1,4,7,10-tetraazacyclododecane-1,7-diacetic acid (trans-H6do2a2p) in solution and in the solid state: structural studies along the series.
Campello MP; Lacerda S; Santos IC; Pereira GA; Geraldes CF; Kotek J; Hermann P; Vanek J; Lubal P; Kubícek V; Tóth E; Santos I
Chemistry; 2010 Jul; 16(28):8446-65. PubMed ID: 20540046
[TBL] [Abstract][Full Text] [Related]
18. Lanthanide complexes of DOTA monoamide derivatives bearing an isophthalate pendent arm.
Shiells EJ; Natrajan LS; Sykes D; Tropiano M; Cooper P; Kenwright AM; Faulkner S
Dalton Trans; 2011 Nov; 40(43):11451-7. PubMed ID: 21952302
[TBL] [Abstract][Full Text] [Related]
19. Converting weak binders into infinite binders.
Corneillie TM; Whetstone PA; Lee KC; Wong JP; Meares CF
Bioconjug Chem; 2004; 15(6):1389-91. PubMed ID: 15546206
[TBL] [Abstract][Full Text] [Related]
20. 17O NMR and density functional theory study of the dynamics of the carboxylate groups in DOTA complexes of lanthanides in aqueous solution.
Mayer F; Platas-Iglesias C; Helm L; Peters JA; Djanashvili K
Inorg Chem; 2012 Jan; 51(1):170-8. PubMed ID: 22128872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
